COMBINATION OF BEVACIZUMAB AND 2,2-DIMETHYL-N-((S)-6-OXO-6,7-DIHYDRO - 5H-DIBENZO[B,D]AZEPIN-7-YL)-N-(2,2,3,3,3-PENTAFLUORO-PROPYL)-MALONAMIDE FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP11781498.8

公开号：

EP2637666A1

申请日:

2011.11.04

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention relates to a combination therapy of 2,2-dimethyl-N-((S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N&prime-(2,2,3,3,3-pentafluoro-propyl)-malonamide, or a pharmaceutically-acceptable salt thereof, and bevacizumab for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example a brain tumor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/